Canadian Pharmacists Journal (CPJ) Best Paper of the Year

Mackenzie d'Entremont-Harris and colleagues; Kyle Wilby

Implementation and acceptance of pharmacists’ prescribing of human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP)

The CPJ Best Paper of the Year award is given by the CPJ Editorial Board to the manuscript judged most likely to positively impact pharmacy practice and lead to better patient care.

This year’s Best Paper describes a study of pharmacist-led PrEP management, guided by a prescribing protocol and implemented at 10 Nova Scotia pharmacies over 6 months. The study, Implementation and acceptance of pharmacists’ prescribing of human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) concluded that pharmacist-led PrEP management can provide an alternative way to obtain PrEP for higher-risk patients. It resulted in a regulation change on July 1, 2024, that authorized pharmacists to prescribe PrEP in Nova Scotia.

The lead author was Mackenzie d’Entremont-Harris; coauthors were Tasha Ramsey, Kathleen MacNabb, Andrea Murphy, Andrea Bishop, Jennifer Isenor, Deborah Kelly, Yazid Al Hamarneh, Matthew Lee, Abbey Ferguson, Kirk Furlotte, Lisa Woodill and Todd Hatchette; and corresponding author was Kyle John Wilby.